Among women not diagnosed with COVID-19 the effect among women with a booster dose (aOR: 0.74; 95% CI: 0.45–1.20) did not reach statistical significance for either vaccination group.
← all excerpts
COVID-19 vaccination status during pregnancy and preeclampsia risk: the pandemic-era cohort of the INTERCOVID consortium.
1
—
—